CANC vs. CNCR ETF Comparison
Comparison of Tema Oncology ETF (CANC) to Loncar Cancer Immunotherapy ETF (CNCR)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$25.94
Average Daily Volume
642
Number of Holdings
*
7
* may have additional holdings in another (foreign) market
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.39
Average Daily Volume
42,856
Number of Holdings
*
71
* may have additional holdings in another (foreign) market
Performance
| Period | CANC | CNCR |
|---|---|---|
| 30 Days | -7.00% | -12.52% |
| 60 Days | -9.03% | -13.52% |
| 90 Days | -1.07% | 2.86% |
| 12 Months | 15.40% |
CANC Underweight 69 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| GERN | A | -2.87% | |
| ACRV | B | -2.63% | |
| ELVN | B | -2.13% | |
| JANX | B | -1.79% | |
| NUVB | B | -1.7% | |
| CGEM | A | -1.57% | |
| RVMD | A | -1.56% | |
| HCM | A | -1.54% | |
| TSVT | F | -1.51% | |
| DAWN | D | -1.5% | |
| BPMC | B | -1.48% | |
| EXEL | A | -1.47% | |
| LYEL | C | -1.46% | |
| YMAB | D | -1.43% | |
| MOR | A | -1.41% | |
| BCYC | C | -1.39% | |
| PGEN | C | -1.39% | |
| INBX | D | -1.38% | |
| ITOS | F | -1.38% | |
| IMCR | D | -1.37% | |
| MGNX | D | -1.37% | |
| NRIX | B | -1.37% | |
| IPHA | D | -1.36% | |
| AURA | D | -1.34% | |
| BNTX | F | -1.33% | |
| RAPT | F | -1.32% | |
| GMAB | F | -1.32% | |
| MRUS | B | -1.32% | |
| VOR | F | -1.32% | |
| BMY | F | -1.31% | |
| SDGR | F | -1.31% | |
| SNDX | C | -1.29% | |
| DCPH | C | -1.29% | |
| ACET | F | -1.28% | |
| TYRA | C | -1.27% | |
| ERAS | D | -1.27% | |
| GLUE | F | -1.26% | |
| IDYA | C | -1.25% | |
| KYMR | D | -1.25% | |
| SWTX | C | -1.23% | |
| PRLD | D | -1.22% | |
| FHTX | F | -1.21% | |
| XNCR | D | -1.21% | |
| STRO | F | -1.21% | |
| KURA | C | -1.2% | |
| IMTX | F | -1.19% | |
| RCUS | D | -1.18% | |
| ZNTL | F | -1.17% | |
| IOVA | D | -1.16% | |
| KPTI | F | -1.14% | |
| NUVL | C | -1.12% | |
| DNA | F | -1.12% | |
| IGMS | D | -1.1% | |
| RLAY | F | -1.09% | |
| ACLX | D | -1.07% | |
| SMMT | C | -1.06% | |
| AUTL | F | -1.04% | |
| RXRX | F | -1.03% | |
| ARVN | D | -1.02% | |
| REPL | F | -1.01% | |
| CRBU | F | -1.01% | |
| LEGN | F | -0.96% | |
| ALLO | F | -0.95% | |
| BMEA | F | -0.9% | |
| RPTX | F | -0.89% | |
| FATE | F | -0.83% | |
| MRSN | D | -0.81% | |
| GNLX | F | -0.78% | |
| IMRX | F | -0.73% |
CANC: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Biotechnology
Diagnostics & Research
Keywords:
Medicine
S&P 500
Antibiotics
Biopharmaceutical
Biotechnology
Infectious Diseases
Inflammation
Nasdaq 100
Ophthalmology
Animal Health
Cancer
Cardiovascular Disease
Clinical Research
Colorectal Cancer
Lab Testing
Life Sciences
Macular Degeneration
Medication
Molecular Diagnostics
Respiratory Diseases
CNCR: Top Represented Industries & Keywords
Compare ETFs
